{"title":"Integrated Bioinformatics and Experimental Validation of Post-Translational Modification-Related Biomarkers in Myocardial Ischemia-Reperfusion Injury.","authors":"Rina Jiang, Yuefeng Li, Kehan Chen, Xiaoping Chen, Yan Liu, Peng Liang, Zhaohe Huang","doi":"10.1007/s12265-026-10821-4","DOIUrl":"10.1007/s12265-026-10821-4","url":null,"abstract":"<p><p>Myocardial ischemia-reperfusion injury (MIRI) lacks fully established post-translational modification (PTM)-associated biomarkers. This study aimed to identify and validate PTM-related MIRI biomarkers through integrated bioinformatics analyses and in vitro experiments. RNA-sequencing datasets were analyzed using weighted gene co-expression network analysis (WGCNA), which identified a brown module strongly associated with the MIRI phenotype. Intersection analysis was performed among the brown gene module, differentially expressed genes, and post-translational modification-related gene sets, two core candidate genes, Myc and Rnf115, were ultimately selected. Both genes demonstrated high diagnostic potential in receiver operating characteristic analyses and exhibited positive correlations with dendritic cell and macrophage infiltration, indicating roles in immune modulation. Hypoxia/reoxygenation assays using H9C2 rat cardiomyocytes confirmed the upregulation of Myc and Rnf115 during early MIRI, aligning with bioinformatics trends. Consequently, Myc and Rnf115 were identified as promising PTM-associated biomarkers potentially involved in MIRI pathogenesis.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148725974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Nicotinamide Mononucleotide Ameliorates Myocardial Fibrosis in Diabetic Mice Possibly by Modulating SIRT3 to Deacetylate GSK3β and Thereby Reducing the Phosphorylation of Smad3.","authors":"Zuowang Ma, Liyang Yao, Kai Zhang, Yu Yang","doi":"10.1007/s12265-026-10827-y","DOIUrl":"10.1007/s12265-026-10827-y","url":null,"abstract":"<p><p>This study aims to investigate the therapeutic potential of NMN in alleviating type 2 diabetes-induced myocardial fibrosis.The experiment was comprised of control group, diabetic group, DM + NMN intervention group, and DM + NMN+3-TYP group. Blood glucose level, tibia length, cardiac function, myocardial interstitial fibrosis and ROS level were evaluated. The expression of SIRT3, GSK3β, ac-GSK3β, downstream fibrosis-related proteins and the interaction between SIRT3 and GSK3β were analyzed. Diabetic mice exhibited pronounced myocardial interstitial fibrosis alongside significant alterations in cardiac structure and function. Additionally, the protein expression levels of ac-GSK3β/GSK3β, p-Smad3/t-Smad3, α-SMA, and Collagen I were elevated, while SIRT3 expression was reduced. NMN effectively ameliorated these changes. The therapeutic benefits of NMN were effectively inhibited by 3-TYP. NMN effectively combats diabetes-induced myocardial fibrosis, potentially through upregulating SIRT3 expression. This upregulation may enhance the interaction between SIRT3 and GSK3β, thereby reducing the acetylation of GSK3β. Through this mechanism, NMN ultimately suppresses Smad3 phosphorylation.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148701317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exercise Preconditioning Activates AMPK-ACC Signaling and Attenuates Myocardial Ischemia/Reperfusion-Induced Ferroptosis.","authors":"Yuxiang Xu, Jie Tang, Chenyang Wu, Ruizhen Li, Yifang Zhao, Mengxin Cai, Zhenjun Tian","doi":"10.1007/s12265-026-10828-x","DOIUrl":"10.1007/s12265-026-10828-x","url":null,"abstract":"<p><p>Ferroptosis critically mediates myocardial ischemia/reperfusion (I/R) injury. Exercise training confers cardioprotection, but whether it protects against I/R-induced ferroptosis and the underlying mechanisms remain unclear. In this study, C57BL/6J mice underwent six weeks of treadmill exercise preconditioning (EP) before myocardial I/R induction. Cardiac function, oxidative stress, ferroptosis markers and the phosphorylation of AMPK and ACC were assessed. In vitro, H9C2 cells were subjected to hypoxia/reoxygenation (H/R), and pharmacological modulators were used to investigate the necessity of the AMPK-ACC signaling. Results showed that EP alleviated I/R-induced cardiac dysfunction, reduced oxidative stress and iron deposition, upregulated GPX4 and SLC7A11 expression, downregulated ACSL4 expression, and enhanced the phosphorylation of AMPK and ACC. In H9C2 cells, H/R reduced ACC phosphorylation and induced ferroptosis. AMPK inhibition exacerbated H/R-induced ferroptosis, whereas AMPK activation by AICAR was protective. Critically, blocking ACC enzymatic activity attenuated AICAR's effects. These findings indicate that EP attenuates I/R-induced ferroptosis and the AMPK-ACC signaling may contribute to this protective effect.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148684602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amanina Athirah Mad Azli, Mohd Helmy Mokhtar, Amilia Aminuddin, Adila A Hamid, Jaya Kumar, Mohd Faizal Ahmad, Azizah Ugusman
{"title":"Empagliflozin Improves Endothelial Function in an Ovariectomized Rat Model of Estrogen Deficiency.","authors":"Amanina Athirah Mad Azli, Mohd Helmy Mokhtar, Amilia Aminuddin, Adila A Hamid, Jaya Kumar, Mohd Faizal Ahmad, Azizah Ugusman","doi":"10.1007/s12265-026-10823-2","DOIUrl":"10.1007/s12265-026-10823-2","url":null,"abstract":"<p><p>Cardiovascular disease risk increases after menopause, largely driven by estrogen deficiency-induced endothelial dysfunction. While sodium-glucose cotransporter 2 (SGLT2) inhibitors confer cardiovascular protection, their vascular effects under estrogen-deficient conditions remain unclear. This study investigated the effects of the SGLT2 inhibitor empagliflozin on vascular function in an ovariectomized (OVX) rat model of estrogen deficiency. Female Sprague-Dawley rats were assigned to control, OVX, OVX + vehicle, OVX + empagliflozin (10 mg/kg/day), and OVX + estradiol (20 µg/kg/day) groups for 28 days. Vascular reactivity was assessed using wire myography, alongside evaluation of endothelial nitric oxide synthase (eNOS) expression and nitric oxide (NO) levels. OVX rats exhibited impaired endothelium-dependent vasorelaxation, increased vasoconstriction, reduced eNOS activation, and decreased NO bioavailability. Empagliflozin significantly improved vascular reactivity, enhanced eNOS activation, and restored NO levels, with effects comparable to estradiol. These findings identify empagliflozin as a potential non-hormonal therapeutic strategy for endothelial dysfunction in postmenopausal conditions.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148684570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Timing and Duration of Prediabetic Metabolic Dysfunction Differentially Impact Cerebral Perfusion, Vascular Structure, and Behavior.","authors":"Annika Matthiesen, Stephanie DiLucia, Riley Feagle, Sadie Lofton, Isabel Marshall, Catrina Robinson, Adviye Ergul","doi":"10.1007/s12265-026-10806-3","DOIUrl":"10.1007/s12265-026-10806-3","url":null,"abstract":"<p><p>Obesity is a major risk factor for metabolic dysfunction and cognitive decline, yet the influence of age of onset and sex on neurovascular outcomes remains unclear. We examined how the age at initiation and duration of diet-induced obesity influence metabolism, cognition, and cerebrovascular perfusion in male and female mice. A high-fat diet increased body weight and impaired glucose regulation, particularly in females. Obesity selectively impaired recognition memory while sparing spatial working memory. Cerebrovascular effects were region- and age-specific. Early- and mid-life obesity produced localized perfusion changes despite preserved global cortical blood flow. In contrast, early-life obesity was associated with reduced cortical perfusion and decreased hippocampal vascular complexity, including fewer branch points and smaller vessel diameters. These alterations parallel recognition memory deficits, suggesting a vascular mechanism linking early metabolic stress to cognitive impairment. Together, our findings identify early-life obesity as a critical window of vulnerability for long-term neurovascular and cognitive dysfunction.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13442511/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exercise-Induced Regulation of LncRNAs: Mechanistic Insights and Clinical Translation in Cardiovascular Health.","authors":"Tao Gao, Li-Hua Yu","doi":"10.1007/s12265-026-10829-w","DOIUrl":"10.1007/s12265-026-10829-w","url":null,"abstract":"<p><p>While exercise training is an established cornerstone for the prevention and treatment of cardiovascular diseases (CVDs), the underlying molecular mechanisms remain incompletely understood. Recent studies have identified long non-coding RNAs (lncRNAs) as critical epigenetic modulators that dynamically respond to physical activity and drive cardiovascular adaptation. This review provides a comprehensive overview of how exercise training reshapes lncRNA transcriptomic landscape to exert cardioprotective effects. Central to this discussion is the elucidation of lncRNA-associated competitive endogenous RNA (ceRNA) networks, which serve as pivotal regulatory axes in exercise-induced cellular responses. Additionally, we highlight the emerging significance of exercise-derived exosomal lncRNAs in mediating inter-organ communication and promoting systemic vascular health. Ultimately, this synthesis delineates current knowledge gaps and future research directions, offering a robust molecular rationale for the development and implementation of personalized exercise prescriptions in clinical cardiology.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Guangfu Liu, Liya Hao, Junfeng Zhang, Yidan Guo, Guangyue Lv, Jiuyuan Liu, Cheng Cheng, Han Yi, Jingjing Zhou, Zhenzhu Liu
{"title":"Beyond the Pump: Unravelling Immunometabolic Crosstalk and Organelle Dynamics in Sepsis-Induced Cardiomyopathy.","authors":"Guangfu Liu, Liya Hao, Junfeng Zhang, Yidan Guo, Guangyue Lv, Jiuyuan Liu, Cheng Cheng, Han Yi, Jingjing Zhou, Zhenzhu Liu","doi":"10.1007/s12265-026-10826-z","DOIUrl":"10.1007/s12265-026-10826-z","url":null,"abstract":"<p><p>Sepsis-induced cardiomyopathy (SICM) has traditionally been viewed as pump-centered contractile failure, but this paradigm fails to explain the clinical spectrum and recovery patterns. This review presents an integrative framework where immunometabolic crosstalk and organelle dysfunction drive disease, including metabolic routing defects, mitochondrial fission, ER stress, and epigenetic regulation via m6A modification and lactylation. Clinically, it proposes a four-phenotype taxonomy (hyperdynamic, hypodynamic, right ventricular-predominant, Takotsubo-like) and advocates for strain imaging and MRI over ejection fraction. Diagnostic innovation includes liquid biopsy for mitochondrial DNA, extracellular vesicles, and metabolomics. Therapeutically, metabolic resuscitation and phenotype-guided vasopressors offer disease modification. The authors call for adaptive trials, biobanking, and organelle-targeted interventions, positioning SICM as a model for precision immunometabolic medicine.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148669617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Autoantibody-Based Models for the Diagnosis and Activity Assessment of Takayasu Arteritis.","authors":"Jianxiong Wu, Jing Cui, Fengjuan Li, Xin Tan, Xue Wang, Yuan Wang","doi":"10.1007/s12265-026-10824-1","DOIUrl":"10.1007/s12265-026-10824-1","url":null,"abstract":"<p><p>The precise diagnosis and activity assessment of Takayasu arteritis (TA) remain challenging. Using a two-phase approach, we screened serum from 9 TA patients and 10 healthy controls via HuProt microarrays, identifying three novel autoantibodies (anti-Table 2, anti-TRAC, anti-LILRA5). These were validated by ELISA in 175 samples (61 active TA, 42 inactive TA, 72 controls). Logistic regression models were developed from training (70%) and test (30%) sets. For diagnosis, Model 1 achieved AUCs of 0.88 and 0.86, outperforming CRP (0.58) and ESR (0.61). For activity assessment, Model 2 achieved AUCs of 0.78 and 0.79, superior to CRP (0.62) and ESR (0.58). These novel autoantibody-based models enable accurate, non-invasive diagnosis and activity assessment in TA.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13433473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148669553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"FOSL2 Regulates PANoptosis in Cardiomyocytes and Heart Failure Progression After Acute Myocardial Infarction by Promoting NLRP12.","authors":"Renlian Gu, Yan Sun","doi":"10.1007/s12265-026-10819-y","DOIUrl":"10.1007/s12265-026-10819-y","url":null,"abstract":"<p><p>NLRP12 can induce PANoptosis, a novel form of inflammatory cell death. The research aimed to investigate the mechanisms of NLRP12 in regulating PANoptosis during postinfarction heart failure (HF). C57BL/6J mice were treated with AAV-shNLRP12 before acute myocardial infarction (AMI) modeling using coronary artery ligation, and mouse cardiomyocytes were treated with lentiviruses before hypoxia. NLRP12 and FOSL2 were upregulated in myocardial tissues of AMI-induced mice and hypoxia-exposed mouse cardiomyocytes. FOSL2 activated NLRP12 in mouse cardiomyocytes by binding to its promoter. Knockdown of FOSL2 or NLRP12 improved survival and inhibited HF after AMI, including recovery of cardiac function, reduction of fibrotic area of myocardial tissues, decrease of myocardial injury, and inhibition of PANoptosis in mice. Combined overexpression of NLRP12 impaired the inhibitory effect of the knockdown of FOSL2 on HF after AMI. Our findings demonstrate that FOSL2 promotes cardiomyocyte PANoptosis by inducing the transcription of NLRP12, thereby triggering HF after AMI.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148603329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Small Animal Models for Translational Research in Atrial Fibrillation.","authors":"Yunmeng Wang, Jiaqi Wang, Yawei Liu, Jingchao Lu","doi":"10.1007/s12265-026-10817-0","DOIUrl":"10.1007/s12265-026-10817-0","url":null,"abstract":"<p><p>Atrial fibrillation (AF) is a common arrhythmia with significant morbidity and mortality, making it essential to conduct in-depth research on its mechanisms and treatments. Animal models are important tools in AF research because they can replicate the key pathophysiological features observed in human AF. This review summarizes various small animal models of AF, focusing on the construction methods of different models, the induction techniques for AF, and the corresponding induction rates, which provide important support for studying the mechanisms of AF and evaluating pharmacological efficacy.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148520531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}